Congress Reviews

I completed my fellowship in Nephrology at Marmara University School of Medicine, Istanbul, Türkiye, in 1999. My primary clinical and…

Before the advent of JAK inhibitors, we did not have any effective therapy for patients with myelofibrosis. We could offer them a…

THE ANNUAL world-leading course in interventional cardiology, EuroPCR, welcomed 12,147 participants to Paris, France, for a dynamic 4-day…

WHEN A LARGE language model (LLM) gives a cardiologist a poor answer, it is not always the model that is the only problem. More often than…

AT EUROPCR 2026, the session ‘All We Need to Know About Vulnerable Plaque’, chaired by Salvatore Brugaletta, Hospital Clínic de Barcelona…

I became interested in nephrology quite early during medical school. I knew that I preferred medical specialties over surgical ones…

I think we should go back a little bit to the pathophysiology of the disease, because this is largely driven by extrahepatic…

The main trend is exactly what we have all been discussing over recent years: MASLD is becoming increasingly prevalent. We already know…